- Home
- PHVS vs CCEC Comparison
PHVS vs CCEC Comparison
Compare PHVS & CCEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PHVS | CCEC |
|---|---|---|
| Founded | 2015 | 2007 |
| Country | Switzerland | Greece |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.2B |
| IPO Year | 2021 | 2007 |
Fundamental Metrics
Financial Performance| Metric | PHVS | CCEC |
|---|---|---|
| Price | $25.82 | $20.64 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 3 |
| Target Price | ★ $39.44 | $25.67 |
| AVG Volume (30 Days) | ★ 532.0K | 11.6K |
| Earning Date | 11-12-2025 | 02-05-2026 |
| Dividend Yield | N/A | ★ 2.86% |
| EPS Growth | N/A | ★ 304.00 |
| EPS | N/A | ★ 4.79 |
| Revenue | N/A | ★ $421,795,000.00 |
| Revenue This Year | N/A | $14.60 |
| Revenue Next Year | N/A | $14.43 |
| P/E Ratio | ★ N/A | $8.15 |
| Revenue Growth | N/A | ★ 32.74 |
| 52 Week Low | $11.51 | $14.09 |
| 52 Week High | $29.80 | $24.83 |
Technical Indicators
Market Signals| Indicator | PHVS | CCEC |
|---|---|---|
| Relative Strength Index (RSI) | 54.34 | 58.57 |
| Support Level | $23.79 | $19.86 |
| Resistance Level | $25.44 | $21.03 |
| Average True Range (ATR) | 1.91 | 0.77 |
| MACD | -0.17 | 0.14 |
| Stochastic Oscillator | 41.22 | 91.41 |
Price Performance
Historical ComparisonAbout PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
About CCEC Capital Clean Energy Carriers Corp.
Capital Clean Energy Carriers Corp is an international shipping company. It is the platform of gas carriage solutions with a focus on the energy transition. The company owns 20 high-specification vessels, including 12 latest-generation LNG carriers (LNG/Cs) and eight legacy Neo-Panamax container vessels.